Oxford Cannabinoid Technologies Stock Debt To Equity
| OCTHF Stock | USD 0 0.00 0.00% |
Oxford Cannabinoid Technologies fundamentals help investors to digest information that contributes to Oxford Cannabinoid's financial success or failures. It also enables traders to predict the movement of Oxford Pink Sheet. The fundamental analysis module provides a way to measure Oxford Cannabinoid's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oxford Cannabinoid pink sheet.
Oxford |
Oxford Cannabinoid Technologies Company Debt To Equity Analysis
Oxford Cannabinoid's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Oxford Cannabinoid Technologies has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 100.0% higher than that of the company.
Oxford Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oxford Cannabinoid's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Oxford Cannabinoid could also be used in its relative valuation, which is a method of valuing Oxford Cannabinoid by comparing valuation metrics of similar companies.Oxford Cannabinoid is currently under evaluation in debt to equity category among its peers.
Oxford Fundamentals
| Current Valuation | (3.87 M) | |||
| Shares Outstanding | 960.42 M | |||
| Shares Owned By Insiders | 44.08 % | |||
| Shares Owned By Institutions | 2.72 % | |||
| Price To Book | 0.41 X | |||
| Gross Profit | (3.15 M) | |||
| EBITDA | (5.63 M) | |||
| Book Value Per Share | 0.01 X | |||
| Market Capitalization | 11.9 M |
About Oxford Cannabinoid Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Oxford Cannabinoid Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oxford Cannabinoid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oxford Cannabinoid Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Oxford Pink Sheet
Oxford Cannabinoid financial ratios help investors to determine whether Oxford Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oxford with respect to the benefits of owning Oxford Cannabinoid security.